Arteris, Inc.
NASDAQ:AIPSemiconductors
+$1.51 today
- Market cap
- $935.54M
- Beta
- 1.99
- P/E (TTM)
- -57.4
- EPS (TTM)
- -$0.76
Volume 0.50M
Average 0.87M
AIP Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Arteris, Inc.NASDAQ: AIP
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $14.46M rose 21.9% year over year, ahead of the +14.1% change in trailing-twelve-month research & development. Sequentially, it rose 9.3% from the prior quarter. Over 3 fiscal years it compounded at +6.6% a year.
Context
- Research & development amounted to 70.7% of revenue in FY2025, down 7.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +21.9% holds above the trailing-twelve-month pace of +14.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 49.91M USD
- Year-over-year change
- +10.9%
- 4-year CAGR
- +12.8%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 49.91M | +10.9% |
| FY2024 | 2024-12-31 | 45.01M | -0.3% |
| FY2023 | 2023-12-31 | 45.13M | +9.6% |
| FY2022 | 2022-12-31 | 41.17M | +33.6% |
| FY2021 | 2021-12-31 | 30.81M | — |
Research & Development vs competitors
How AIP compares with its peers on the latest reported figures
- AIP's LTM Mar 2026 research & development of $52.5M is the 3rd highest of the 5 companies compared; the peer median is $59.68M.
- Its year-over-year change of +14.1% is the 2nd highest of 5, against a peer median of +5.8%.
- Research & development amounts to 68.2% of revenue for AIP, versus a peer median of 49.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.88B | +26.0% | +16.0% | 30.6% | |
| LTM Mar 2026 | $77M | +8.1% | +2.1% | 68.5% | |
| LTM Mar 2026 | $52.5M | +14.1% | +6.6% | 68.2% | |
| LTM Mar 2026 | $42.36M | +3.5% | -9.8% | 60.0% | |
| LTM Mar 2026 | $5.54M | -10.3% | +1.9% | 38.2% | |
| Peer median (excluding AIP) | $59.68M | +5.8% | +2.0% | 49.1% | |
Competitors are the stored peer set for AIP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 37.86M | 50.38M | 53.67M | 57.72M | 70.58M |
| Cost of Revenue | 3.73M | 4.28M | 5.08M | 5.96M | 6.9M |
| Gross Profit | 34.13M | 46.1M | 48.59M | 51.76M | 63.68M |
| Gross Margin | 90.1% | 91.5% | 90.5% | 89.7% | 90.2% |
| Research & Development | 30.81M | 41.17M | 45.13M | 45.01M | 49.91M |
| Selling, General & Admin | 25.09M | 33.79M | 38.6M | 38.35M | 46.91M |
| Operating Expenses | 55.9M | 74.95M | 83.73M | 83.36M | 96.82M |
| Depreciation & Amortization | 1.49M | 2.1M | 3.07M | 3.36M | 3.38M |
| EBITDA | (20.27M) | (25.33M) | (28.52M) | (24.83M) | (29.7M) |
| EBITDA Margin | -53.5% | -50.3% | -53.1% | -43.0% | -42.1% |
| Operating Income | (21.77M) | (28.86M) | (35.14M) | (31.6M) | (33.14M) |
| Operating Margin | -57.5% | -57.3% | -65.5% | -54.7% | -47.0% |
| Interest Income | 0 | 1.43M | 0 | 0 | 0 |
| Interest Expense | 579K | 89K | 211K | 244K | 193K |
| Other Income / Expenses | (579K) | 1.05M | (50K) | 458K | (134K) |
| Income Before Tax | (22.34M) | (27.8M) | (35.19M) | (31.14M) | (33.27M) |
| Pre-Tax Margin | -59.0% | -55.2% | -65.6% | -53.9% | -47.1% |
| Income Tax Expense | 1.04M | (417K) | 1.68M | 2.5M | 1.48M |
| Net Income | (23.38M) | (27.39M) | (36.87M) | (33.64M) | (34.75M) |
| Net Margin | -61.8% | -54.4% | -68.7% | -58.3% | -49.2% |
| EPS (Basic) | (1.06) | (0.84) | (1.03) | (0.86) | (0.82) |
| EPS (Diluted) | (1.06) | (0.84) | (1.03) | (0.86) | (0.82) |
| Weighted Avg Shares | 21.97M | 32.58M | 35.68M | 38.91M | 42.29M |
| Weighted Avg Shares (Diluted) | 21.97M | 32.58M | 35.68M | 38.91M | 42.29M |
Arteris, Inc.
NASDAQ:AIP
Intrinsic Alpha fair value
Locked
Current Price
$18.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.